Literature DB >> 24974367

Access to harm reduction programs among persons who inject drugs: findings from a respondent-driven sampling survey in Tehran, Iran.

Ruyan Rahnama1, Minoo Mohraz2, Ali Mirzazadeh3, George Rutherford4, Willi McFarland5, Gholamreza Akbari2, Mohsen Malekinejad6.   

Abstract

BACKGROUND: Over the past two decades, drug injection-related risk behaviors have been the major drivers of the HIV epidemic in Iran. This study assesses the access of people who injected drugs (PWID) to harm reduction services (needle-exchange programs [NEP] and methadone maintenance treatment [MMT]) in Tehran, Iran in 2007, almost five years after the large-scale implementation of these programs.
METHODS: 572 consenting PWID (>18 years old, ever injected in the past month, lived in Tehran or its suburbs) were recruited (24 seeds) into a sero-behavioral survey using respondent-driven sampling method. Participants completed a face-to-face interview about HIV-related risk behaviors and access to harm reduction services. We calculated adjusted population estimates using RDSAT.
RESULTS: Overall, 99.2% of the participants were male, 41.6% aged between 30 and 39 years old, 55.4% lived alone in the past year, 83.2% were ever incarcerated, and 88.8% lived in the southern areas of Tehran. In terms of "awareness" and "use" of services among PWID, 62.8% and 54.8% reported for NEP (respectively) and 19.7% and 9.1% for drug treatment services (respectively). PWID who lived in Northwest and South-central Tehran were more likely to be aware (85.0% and 82.8%, respectively) of one or more services than PWID who lived elsewhere. Similarly, PWID who lived with friends were more likely to be aware of (88.6%) and use (85.9%) services (vs. other living partners). Overall, 11% of the participants were aware of but had not used any harm reduction services.
CONCLUSIONS: Despite a relatively high level of access to NEP among PWID in Tehran, a sizable fraction of the population remains without access to other services five years after their implementation. The use of harm reduction may be affected by certain PWID characteristics (e.g., living partners and geographical location). Ongoing surveillance activities are necessary to track change in access over time.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HIV; Harm reduction; Injection-drug use; Iran; Methadone; Needle-exchange programs; Respondent-driven sampling

Mesh:

Year:  2014        PMID: 24974367      PMCID: PMC4231781          DOI: 10.1016/j.drugpo.2014.05.013

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  12 in total

Review 1.  HIV prevalence amongst injecting drug users in Iran: a systematic review of studies conducted during the decade 1998-2007.

Authors:  Afarin Rahimi-Movaghar; Masoumeh Amin-Esmaeili; Ali-Akbar Haghdoost; Behnam Sadeghirad; Minoo Mohraz
Journal:  Int J Drug Policy       Date:  2011-10-14

2.  HIV/AIDS among female sex workers, injecting drug users and men who have sex with men in Lebanon: results of the first biobehavioral surveys.

Authors:  Ziyad Mahfoud; Rema Afifi; Sami Ramia; Danielle El Khoury; Kassem Kassak; Farah El Barbir; Maguy Ghanem; Mostafa El-Nakib; Jocelyn DeJong
Journal:  AIDS       Date:  2010-07       Impact factor: 4.177

3.  Evaluation of respondent-driven sampling.

Authors:  Nicky McCreesh; Simon D W Frost; Janet Seeley; Joseph Katongole; Matilda N Tarsh; Richard Ndunguse; Fatima Jichi; Natasha L Lunel; Dermot Maher; Lisa G Johnston; Pam Sonnenberg; Andrew J Copas; Richard J Hayes; Richard G White
Journal:  Epidemiology       Date:  2012-01       Impact factor: 4.822

4.  Characteristics of Iranian women seeking drug treatment.

Authors:  Kate Dolan; Shabnam Salimi; Bijan Nassirimanesh; Setareh Mohsenifar; David Allsop; Azarakhsh Mokri
Journal:  J Womens Health (Larchmt)       Date:  2011-09-09       Impact factor: 2.681

5.  Transition to injection amongst opioid users in Iran: implications for harm reduction.

Authors:  Mohsen Malekinejad; Mohsen Vazirian
Journal:  Int J Drug Policy       Date:  2011-10-13

6.  HIV risk behavior among injection drug users in Tehran, Iran.

Authors:  Nooshin Razani; Minoo Mohraz; Parastoo Kheirandish; Mohsen Malekinejad; Hossein Malekafzali; Azarakhsh Mokri; Willi McFarland; George Rutherford
Journal:  Addiction       Date:  2007-07-23       Impact factor: 6.526

7.  HIV surveillance and epidemic profile in the Middle East and North Africa.

Authors:  Sherine Shawky; Cherif Soliman; Kassem M Kassak; Doaa Oraby; Danielle El-Khoury; Inoussa Kabore
Journal:  J Acquir Immune Defic Syndr       Date:  2009-07-01       Impact factor: 3.731

8.  Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: a cross-sectional study.

Authors:  Mohsen Vazirian; Bijan Nassirimanesh; Saman Zamani; Masako Ono-Kihara; Masahiro Kihara; Shahrzad Mortazavi Ravari; Mohammad Mehdi Gouya
Journal:  Harm Reduct J       Date:  2005-10-07

9.  Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries.

Authors:  Zaino Petersen; Bronwyn Myers; Marie-Claire van Hout; Andreas Plüddemann; Charles Parry
Journal:  Harm Reduct J       Date:  2013-08-19

10.  Profiles of risk: a qualitative study of injecting drug users in Tehran, Iran.

Authors:  Emran M Razzaghi; Afarin Rahimia Movaghar; Traci Craig Green; Kaveh Khoshnood
Journal:  Harm Reduct J       Date:  2006-03-18
View more
  9 in total

1.  The evidence does not speak for itself: The role of research evidence in shaping policy change for the implementation of publicly funded syringe exchange programs in three US cities.

Authors:  Sean T Allen; Monica S Ruiz; Allison O'Rourke
Journal:  Int J Drug Policy       Date:  2015-04-15

Review 2.  HIV and the criminalisation of drug use among people who inject drugs: a systematic review.

Authors:  Kora DeBeck; Tessa Cheng; Julio S Montaner; Chris Beyrer; Richard Elliott; Susan Sherman; Evan Wood; Stefan Baral
Journal:  Lancet HIV       Date:  2017-05-14       Impact factor: 12.767

3.  Syringe Sharing in Drug Injecting Dyads: A Cross-Classified Multilevel Analysis of Social Networks.

Authors:  Armita Shahesmaeili; Ali Mirzazadeh; Willi McFarland; Hamid Sharifi; Ali Akbar Haghdoost; Hamid Soori
Journal:  AIDS Behav       Date:  2018-07

Review 4.  High hepatitis C virus prevalence among drug users in Iran: systematic review and meta-analysis of epidemiological evidence (2001-2012).

Authors:  Mohsen Malekinejad; Soodabeh Navadeh; Ali Lotfizadeh; Afarin Rahimi-Movaghar; Masoumeh Amin-Esmaeili; Alireza Noroozi
Journal:  Int J Infect Dis       Date:  2015-10-13       Impact factor: 3.623

5.  Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme.

Authors:  Angelos Hatzakis; Vana Sypsa; Dimitrios Paraskevis; Georgios Nikolopoulos; Chrissa Tsiara; Katerina Micha; Anastasios Panopoulos; Meni Malliori; Mina Psichogiou; Anastasia Pharris; Lucas Wiessing; Marita van de Laar; Martin Donoghoe; Douglas D Heckathorn; Samuel R Friedman; Don C Des Jarlais
Journal:  Addiction       Date:  2015-07-14       Impact factor: 6.526

Review 6.  HIV in Iran: onset, responses, and future directions.

Authors:  SeyedAhmad SeyedAlinaghi; Leila Taj; Elham Mazaheri-Tehrani; Sara Ahsani-Nasab; Negin Abedinzadeh; Willi McFarland; Minoo Mohraz; Ali Mirzazadeh
Journal:  AIDS       Date:  2021-03-15       Impact factor: 4.632

7.  Declining trends in exposures to harmful policing among people who inject drugs in Vancouver, Canada.

Authors:  Adina Landsberg; Thomas Kerr; Michael-John Milloy; Huiru Dong; Paul Nguyen; Evan Wood; Kanna Hayashi
Journal:  J Int AIDS Soc       Date:  2016-07-18       Impact factor: 5.396

8.  'You just prefer to die early!': how socioecological context impedes treatment for people living with HIV in Iran.

Authors:  Vira Ameli; Leila Taj; Jane Barlow; Lora Sabin; Franziska Meinck; Jessica Haberer; Minoo Mohraz
Journal:  BMJ Glob Health       Date:  2021-11

9.  Typology of Street Substance Users' Communities in Tehran, Iran.

Authors:  Masoomeh Maarefvand; Mohammad Sadegh Shirazi; Raha Peyravi; Ali Farhoudian
Journal:  Addict Health       Date:  2017-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.